524 related articles for article (PubMed ID: 30097223)
1. Red Blood Cell Alloimmunization in the Pregnant Patient.
Webb J; Delaney M
Transfus Med Rev; 2018 Oct; 32(4):213-219. PubMed ID: 30097223
[TBL] [Abstract][Full Text] [Related]
2. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
[TBL] [Abstract][Full Text] [Related]
3. Hemolytic Disease of the Fetus and Newborn: Modern Practice and Future Investigations.
Hendrickson JE; Delaney M
Transfus Med Rev; 2016 Oct; 30(4):159-64. PubMed ID: 27397673
[TBL] [Abstract][Full Text] [Related]
4. Hemolytic disease of the fetus and newborn due to multiple maternal antibodies.
Markham KB; Rossi KQ; Nagaraja HN; O'Shaughnessy RW
Am J Obstet Gynecol; 2015 Jul; 213(1):68.e1-68.e5. PubMed ID: 25644438
[TBL] [Abstract][Full Text] [Related]
5. Risk of maternal alloimmunization in Southern Pakistan - a study in a cohort of 1000 pregnant women.
Karim F; Moiz B; Kamran N
Transfus Apher Sci; 2015 Feb; 52(1):99-102. PubMed ID: 25532481
[TBL] [Abstract][Full Text] [Related]
6. Update on HDFN: new information on long-standing controversies.
Eder AF
Immunohematology; 2006; 22(4):188-95. PubMed ID: 17430078
[TBL] [Abstract][Full Text] [Related]
7. [Haemolytic disease of the fetus and newborn/HDFN/timing in pregnant women and prophylaxis].
Kulinska R
Akush Ginekol (Sofiia); 2014; 53(2):58-63. PubMed ID: 25098112
[TBL] [Abstract][Full Text] [Related]
8. Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn.
Delaney M; Matthews DC
Hematology Am Soc Hematol Educ Program; 2015; 2015():146-51. PubMed ID: 26637714
[TBL] [Abstract][Full Text] [Related]
9. Receipt of RhD-positive whole blood for life-threatening bleeding in female children: A survey in alloimmunized mothers regarding minimum acceptable survival benefit relative to risk of maternal alloimmunization to anti-D.
Sherwood MR; Clayton S; Leeper CM; Yazer M; Moise KJ; Granger ME; Spinella PC
Transfusion; 2024 May; 64 Suppl 2():S100-S110. PubMed ID: 38563495
[TBL] [Abstract][Full Text] [Related]
10. Neonatal and Obstetrical Outcomes of Pregnancies Complicated by Alloimmunization.
Bahr TM; Tweddell SM; Zalla JM; Dizon-Townson D; Ohls RK; Henry E; Ilstrup SJ; Kelley WE; Ling CY; Lindgren PC; O'Brien EA; Christensen RD
Pediatrics; 2024 Jun; 153(6):. PubMed ID: 38784990
[TBL] [Abstract][Full Text] [Related]
11. Impact of red blood cell alloimmunization on fetal and neonatal outcomes: A single center cohort study.
Lieberman L; Callum J; Cohen R; Cserti-Gazdewich C; Ladhani NNN; Buckstein J; Pendergrast J; Lin Y
Transfusion; 2020 Nov; 60(11):2537-2546. PubMed ID: 32893897
[TBL] [Abstract][Full Text] [Related]
12. [Management of feto-maternal red cell allo-immunizations].
Bricca P; Guinchard E; Guitton Bliem C
Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546
[TBL] [Abstract][Full Text] [Related]
13. Third trimester screening for alloimmunisation in Rhc-negative pregnant women: evaluation of the Dutch national screening programme.
Slootweg YM; Koelewijn JM; van Kamp IL; van der Bom JG; Oepkes D; de Haas M
BJOG; 2016 May; 123(6):955-63. PubMed ID: 26661943
[TBL] [Abstract][Full Text] [Related]
14. Immunological principle of development of red blood cell alloimmunization in pregnancy, hemolytic disease of the fetus and prevention of RhD alloimmunization in RhD negative women.
Roubalová L; Lubušký M
Ceska Gynekol; 2020; 85(6):408-416. PubMed ID: 33711901
[TBL] [Abstract][Full Text] [Related]
15. Non-anti-D antibodies in red-cell alloimmunization.
Lobo GA; Nardozza LM; Camano L
Int J Gynaecol Obstet; 2006 Aug; 94(2):139-40. PubMed ID: 16828096
[No Abstract] [Full Text] [Related]
16. [Positive Coomb's test in newborns; causes and clinical consequences Summary of cases diagnosed in the Blood Bank in the years 2005 to 2012].
Kristinsdottir T; Kjartansson S; Hardardottir H; Jonsson T; Halldorsdottir AM
Laeknabladid; 2016 Jul; 102(7-8):326-31. PubMed ID: 27531851
[TBL] [Abstract][Full Text] [Related]
17. Haemolytic disease of the fetus and newborn.
de Haas M; Thurik FF; Koelewijn JM; van der Schoot CE
Vox Sang; 2015 Aug; 109(2):99-113. PubMed ID: 25899660
[TBL] [Abstract][Full Text] [Related]
18. [Hemolytic disease of the newborn and irregular blood group antibodies in the Netherlands: prevalence and morbidity].
van Dijk BA; Hirasing RA; Overbeeke MA
Ned Tijdschr Geneeskd; 1999 Jul; 143(28):1465-9. PubMed ID: 10443262
[TBL] [Abstract][Full Text] [Related]
19. Severe hemolytic disease of fetus and newborn caused by red blood cell antibodies undetected at first-trimester screening (CME).
Dajak S; Stefanović V; Capkun V
Transfusion; 2011 Jul; 51(7):1380-8. PubMed ID: 21214583
[TBL] [Abstract][Full Text] [Related]
20. High anti-HLA response in women exposed to intrauterine transfusions for severe alloimmune hemolytic disease is associated with mother-child HLA triplet mismatches, high anti-D titer, and new red blood cell antibody formation.
Verduin EP; Schonewille H; Brand A; Haasnoot GW; Claas FH; Lindenburg IT; Lopriore E; Oepkes D; Roelen DL; Doxiadis II
Transfusion; 2013 May; 53(5):939-47. PubMed ID: 22924899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]